Clinical Trial Update: Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of a liposome-encapsulated combination therapy for younger patients with relapsed or refractory acute myeloid leukemia, completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• liposome-encapsulated daunorubicin-cytarabine, fludarabine phosphate, cytarabine, and filgrastim

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Childhood Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-12-30